NM_001142800.2:c.1146T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001142800.2(EYS):​c.1146T>C​(p.Asn382Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 1,529,430 control chromosomes in the GnomAD database, including 201,288 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 20917 hom., cov: 32)
Exomes 𝑓: 0.51 ( 180371 hom. )

Consequence

EYS
NM_001142800.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.00200

Publications

24 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-65402516-A-G is Benign according to our data. Variant chr6-65402516-A-G is described in ClinVar as Benign. ClinVar VariationId is 137262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.002 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 43 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 44 NP_001278938.1 Q5T1H1-3
EYSNM_001142801.2 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 12 NP_001136273.1 Q5T1H1-4
EYSNM_198283.2 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 6 of 10 NP_938024.1 Q5T1H1-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 43 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 44 1 ENSP00000359655.3 Q5T1H1-3
EYSENST00000393380.6 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 7 of 12 1 ENSP00000377042.2 Q5T1H1-4
EYSENST00000342421.9 linkc.1146T>C p.Asn382Asn synonymous_variant Exon 5 of 9 1 ENSP00000341818.5 Q5T1H1-2

Frequencies

GnomAD3 genomes
AF:
0.524
AC:
79538
AN:
151706
Hom.:
20891
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.654
Gnomad AMR
AF:
0.538
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.467
Gnomad SAS
AF:
0.537
Gnomad FIN
AF:
0.539
Gnomad MID
AF:
0.526
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.528
GnomAD2 exomes
AF:
0.519
AC:
129770
AN:
249798
AF XY:
0.519
show subpopulations
Gnomad AFR exome
AF:
0.528
Gnomad AMR exome
AF:
0.558
Gnomad ASJ exome
AF:
0.578
Gnomad EAS exome
AF:
0.443
Gnomad FIN exome
AF:
0.536
Gnomad NFE exome
AF:
0.508
Gnomad OTH exome
AF:
0.524
GnomAD4 exome
AF:
0.510
AC:
702437
AN:
1377606
Hom.:
180371
Cov.:
26
AF XY:
0.511
AC XY:
352198
AN XY:
689744
show subpopulations
African (AFR)
AF:
0.532
AC:
16788
AN:
31578
American (AMR)
AF:
0.554
AC:
24624
AN:
44412
Ashkenazi Jewish (ASJ)
AF:
0.570
AC:
14526
AN:
25488
East Asian (EAS)
AF:
0.444
AC:
17362
AN:
39092
South Asian (SAS)
AF:
0.526
AC:
44250
AN:
84146
European-Finnish (FIN)
AF:
0.536
AC:
28515
AN:
53222
Middle Eastern (MID)
AF:
0.531
AC:
2968
AN:
5586
European-Non Finnish (NFE)
AF:
0.506
AC:
524025
AN:
1036618
Other (OTH)
AF:
0.511
AC:
29379
AN:
57464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
14458
28917
43375
57834
72292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14854
29708
44562
59416
74270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.524
AC:
79619
AN:
151824
Hom.:
20917
Cov.:
32
AF XY:
0.529
AC XY:
39214
AN XY:
74188
show subpopulations
African (AFR)
AF:
0.536
AC:
22215
AN:
41410
American (AMR)
AF:
0.538
AC:
8176
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
1995
AN:
3468
East Asian (EAS)
AF:
0.468
AC:
2411
AN:
5156
South Asian (SAS)
AF:
0.537
AC:
2582
AN:
4810
European-Finnish (FIN)
AF:
0.539
AC:
5698
AN:
10562
Middle Eastern (MID)
AF:
0.514
AC:
149
AN:
290
European-Non Finnish (NFE)
AF:
0.511
AC:
34689
AN:
67922
Other (OTH)
AF:
0.526
AC:
1110
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1924
3849
5773
7698
9622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.516
Hom.:
34166
Bravo
AF:
0.524
Asia WGS
AF:
0.475
AC:
1648
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 05, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 17, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 25 Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.10
DANN
Benign
0.27
PhyloP100
0.0020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs974110; hg19: chr6-66112409; COSMIC: COSV60985754; API